GSK recalls 600,000 Ventolin Inhalers from US
Multinational pharmaceutical company, GlaxoSmithKline (GSK) has announced the recall of over 590,000 Salbutamol (Ventolin) inhalers from the US market, saying there could be issues with the delivery technique.
The recall is for three lots of Ventolin HFA 200D inhalers with lot numbers 6ZP0003, 6ZP9944 and 6ZP9848.
The inhalers, according to reports, have been distributed to hospitals, pharmacies, retailers and wholesalers in the United States.
“There is attainable risk that the affected inhalers could potentially not deliver the stated number of actuations,” according to GSK spokesman Juan Carlos Molina. “We continue to investigate the situation in order to identify the root lead to and implement appropriate corrective and preventative actions.”
The recall is not directed at individuals, but those with inhalers from the recalled lots have been advised to contact the company.
About author
You might also like
NASS to compel FG to implement National Health Act in 2017 – Tejuoso
The National Assembly has pledged to ensure that the Federal Government implements the National Health Act which was signed into law in 2014 by former President Goodluck Jonathan, Chairman, Senate
FG designates 6 labs for lassa fever detection
We will concentrate on prevention because currently, there is no vaccine as of today. I have been notified of a candidate vaccine which we will put through clinical trial to
INCB report makes case for women
Calls for gender-sensitive policies Says women are more likely to be prescribed narcotics and anti-anxiety medication Advocates urgent health-care access for drugs-dependent women Experts have called for gender-sensitive policies and
0 Comments
No Comments Yet!
You can be first to comment this post!